Filament BioSolutions Partners with Canadian Academic Centers to Study Precision Nutritional Therapies

Filament BioSolutions Partners with Canadian Academic Centers to Study Precision Nutritional Therapies
Filament BioSolutions announced a partnership with the University of Ottawa and the Children’s Hospital of Eastern Ontario (CHEO) to conduct a $7.4 million study of clinical applications of microbiome-based precision nutrition for treating inflammatory bowel disease (IBD). Filament is a clinical nutrition company developing therapeutic nutrition products to improve patient health. In this project, Filament will support the

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *